Although conventional IBD surgery can be performed using a minimally invasive approach, controversy surrounds the role of laparoscopy in the surgical management of IBD. The authors of this Review ...

In an interview with HT Lifestyle, Dr Anukalp Prakash, Director of Gastroenterology at CK Birla, Gurugram, shared the key differences between IBS, IBD, and their symptoms, diagnosis and treatments.

While HSCT is currently indicated for only a subset of patients with monogenic IBD, insights gained from studying these cases may inform the development of novel therapeutic targets for the ...

The relationship between IBD and immune system dysfunction Unlike classic autoimmune conditions where the immune system directly attacks healthy tissues with specific autoantibodies, IBD involves ...

At the IBD Nexus Summit 2025, Dr Heba Al-Farhan, Consultant Gastroenterologist & Hepatologist – Advanced IBD Specialist, among the many distinguished healthcare professionals present, discussed ...

Johnson & Johnson JNJ announced that the FDA has granted approval to its key drug, Tremfya, for its second inflammatory bowel disease (IBD) condition — moderately to severely active Crohn’s ...

The review, published in Clinical Gastroenterology and Hepatology, encompassed the current landscape of IBD care, highlighting challenges with achieving cost sustainability in the space as well as ...

People living with inflammatory bowel disease (IBD) have new hope, with clinical trials beginning for a breakthrough treatment for one of the most difficult to treat conditions associated with the ...

The use of long-acting reversible contraceptive methods—the most effective form of contraception— is low among women with IBD, although active IBD at conception is associated with adverse ...

Case Study Published: April 2007 Colonic infiltration with chronic myelomonocytic leukemia Andelka D LoSavio, Alana P Bunnag & David T Rubin Nature Clinical Practice Gastroenterology & Hepatology ...

Despite the enthusiasm around AbbVie’s fast-rising up-and-coming blockbuster Skyrizi, Entyvio's growth “continues to outperform” the overall IBD market, according to Takeda's recent investor ...

Stress can worsen IBD symptoms in several ways. It can increase inflammation in the gut and disrupt the balance of good and bad bacteria. When you're stressed, your body releases hormones that can ...